by Mike Regan | Jun 30, 2022 | Company Analysis
Canopy Growth (CGC) is issuing between 56.7-78.4 million shares to retire C$255.4 million of its C$600 million convertible note due 2023. The conversion price for this redemption works out to somewhere between US$2.50-3.50, and will be based on the 10 day average...
by Mike Regan | Jun 6, 2022 | Company Analysis
This is a follow-up to the January 16, 2022 article analyzing the contractually mandated dilution due to existing contracts at the Parent Company, which noted the potential signaling by the recipients. The 1Q22 10Q answers that question: This article is for...
by Mike Regan | Jun 6, 2022 | Comp Table & Market Commentary, Company Analysis
You may have heard about the roller coaster direct listing (NOT an IPO) of Bright Green Corp (BGXX), a company that plans to cultivate cannabis for pharmaceutical research under a license from the DEA. This has little read through to the rest of the US cannabis...
by Mike Regan | Jun 2, 2022 | Comp Table & Market Commentary, Company Analysis, Free, In the News, Macro, Podcast, Regional Data, Weekly Extract
Thanks to Rena Sherbill of Seeking Alpha’s Cannabis Investing Podcast for interviewing Mike and thanks to Colin Ferrian for joining our chat and getting the band back together for a one-off conversation. To quote the summary and transcript (available here) of...
by Mike Regan | Apr 29, 2022 | Company Analysis
Agrify’s 2021 Proxy came out this morning, and there is more information regarding the ownership of the largest customer (as detailed in this post on 4/1/21), as well as the share authorization. This also includes the takeaways from Benzinga, insights into the new...
by Mike Regan | Apr 27, 2022 | Company Analysis, Weekly Extract
On April 20-21, Benzinga hosted their Cannabis Capital Conference in Miami. It was quite well attended with maybe ~1500 people, and standing room only for Boris Jordan’s first presentation of the day. Benzinga has now posted videos of most presentations here Premium...
